Results 201 to 210 of about 66,023 (384)

Pre-implantation genetic diagnosis: a case for law reform [PDF]

, 2003
Garwood-Gowers, A
core  

On Cleavage of the Unfertilized Ovum of Rat

, 1959
Isao Ishibashi
openalex   +2 more sources

Poly I:C accelerates ovum transport in the rabbit by a prostaglandin-mediated mechanism [PDF]

, 1981
M. J. K. Harper, Catherine J. Norris, William E. Friedrichs, A. Moreno   +3 more
openalex   +1 more source

Dropsy of the Ovum:

n ...
openaire   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source

Exploration of Conditions for the Scaled Application of Laparoscopic Ovum Pick-Up in Sheep and Comparison of Follicular Development Differences Among Breeds. [PDF]

Int J Mol Sci
Li D, Wu X, Chen Y, Wu Y, Abudureyimu G, Liang H, Ma X, Zhang W, Wang L, Lin J.   +9 more
europepmc   +1 more source

Ovulation Regulation [PDF]

, 1965
Groden, Harold M.
core   +1 more source

Linacre Institute Paper: Moral and Medical Considerations in the Management of Extrauterine Pregnancy [PDF]

, 1999
Diamond, Eugene F.
core   +2 more sources

Time relations of squirrel monkey (Saimiri sciureus) sperm capacitation and ovum maturation in an in-vitro fertilization system [PDF]

, 1982
Thomas J. Kuehl, W. Richard Dukelow
openalex   +1 more source

Unlocking the power of immune checkpoint inhibitors: Targeting YAP1 reduces anti‐PD1 resistance in skin cutaneous melanoma

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Immune checkpoint inhibitors, such as anti­PD1, revolutionized melanoma treatment. However, resistance and low response rates remain problems. Our goal was to pinpoint actionable biomarkers of resistance to anti‐PD1 treatment and verify therapeutic effectiveness in vivo.
Szonja Anna Kovács, Tamás Kovács, András Lánczky, Ágnes Paál, Zsombor I. Hegedűs, Nabil V. Sayour, Lilla Szabó, Andrea Kovács, Giampaolo Bianchini, Péter Ferdinandy, Alberto Ocana, Zoltán V. Varga, János Tibor Fekete, Balázs Győrffy   +13 more
wiley   +1 more source